Literature DB >> 10446378

Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates.

P Masson1, W Xie, M T Froment, V Levitsky, P L Fortier, C Albaret, O Lockridge.   

Abstract

Human butyrylcholinesterase displays substrate activation with positively charged butyrylthiocholine (BTC) as the substrate. Peripheral anionic site (PAS) residues D70 and Y332 appear to be involved in the initial binding of charged substrates and in activation control. To determine the contribution of PAS residues to binding and hydrolysis of quaternary substrates and activation control, the single mutants D70G/Y and Y332F/A/D and the double mutants Y332A/D70G and Y332D/D70Y were studied. Steady-state hydrolysis of the charged substrates, BTC and succinyldithiocholine, and the neutral ester o-nitrophenyl butyrate was measured. In addition, inhibition of wild-type and mutant enzymes by tetramethylammonium was investigated, at low concentrations of BTC. Single and double mutants of D70 and Y332 showed little or no substrate activation, suggesting that both residues were important for activation control. The effects of double mutations on D70 and Y332 were complex. Double-mutant cycle analysis provided evidence for interaction between these residues. The category of interaction (either synergistic, additive, partially additive or antagonistic) was found to depend on the nature of the substrate and on measured binding or kinetic parameters. This complexity reflects both the cross-talk between residues involved in the sequential formation of productive Michaelian complexes and the effect of peripheral site residues on catalysis. It is concluded that double mutations on the PAS induce a conformational change in the active site gorge of butyrylcholinesterase that can alter both substrate binding and enzyme acylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446378     DOI: 10.1016/s0167-4838(99)00115-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.

Authors:  Liu Xue; Mei-Chuan Ko; Min Tong; Wenchao Yang; Shurong Hou; Lei Fang; Junjun Liu; Fang Zheng; James H Woods; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Mol Pharmacol       Date:  2010-10-22       Impact factor: 4.436

2.  Computational redesign of human butyrylcholinesterase for anticocaine medication.

Authors:  Yongmei Pan; Daquan Gao; Wenchao Yang; Hoon Cho; Guangfu Yang; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

3.  Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase.

Authors:  Daquan Gao; Chang-Guo Zhan
Journal:  Proteins       Date:  2006-01-01

4.  Pressure- and heat-induced inactivation of butyrylcholinesterase: evidence for multiple intermediates and the remnant inactivation process.

Authors:  A Weingand-Ziade; F Ribes; F Renault; P Masson
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

5.  Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.

Authors:  Adel Hamza; Hoon Cho; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2005-03-17       Impact factor: 2.991

6.  Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.

Authors:  Fang Zheng; Wenchao Yang; Liu Xue; Shurong Hou; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2010-10-26       Impact factor: 3.162

7.  Human butyrylcholinesterase-cocaine binding pathway and free energy profiles by molecular dynamics and potential of mean force simulations.

Authors:  Xiaoqin Huang; Fang Zheng; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2011-09-08       Impact factor: 2.991

8.  Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.

Authors:  Lei Fang; Shurong Hou; Liu Xue; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2014-02-25       Impact factor: 5.192

9.  Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase.

Authors:  Xiabin Chen; Xiaoqin Huang; Liyi Geng; Liu Xue; Shurong Hou; Xirong Zheng; Stephen Brimijoin; Fang Zheng; Chang-Guo Zhan
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

Review 10.  Rational design of an enzyme mutant for anti-cocaine therapeutics.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.